« Back to Research Deepdives

Relationship Between B-vitamins, Omega-3’s, and Cognitive Function

This content is restricted to members.

To view our premium content, sign up for a membership:


Register New Account

Choose your membership level

Choose Your Payment Method

‹ Back to Research Deepdives


  1. Barberger-Gateau P, Letenneur L, Deschamps V, Pérès K, Dartigues J, Renaud S. Fish, meat, and risk of dementia: cohort study. BMJ. 2002;325(7370):932-933.
  2. Morris M, Evans D, Bienias J, Tangney C, Bennett D, Wilson R et al. Consumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease. Archives of Neurology. 2003;60(7):940.
  3. Morris M, Brockman J, Schneider J, Wang Y, Bennett D, Tangney C et al. Association of Seafood Consumption, Brain Mercury Level, and APOE ε4 Status With Brain Neuropathology in Older Adults. JAMA. 2016;315(5):489.
  4. Cunnane S, Chouinard-Watkins R, Castellano C, Barberger-Gateau P. Docosahexaenoic acid homeostasis, brain aging and Alzheimer’s disease: Can we reconcile the evidence?. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2013;88(1):61-70.
  5. Savage D, Lindenbaum J. Neurological complications of acquired cobalamin deficiency: clinical aspects. Baillière’s Clinical Haematology. 1995;8(3):657-678.
  6. Mandaviya P, Stolk L, Heil S. Homocysteine and DNA methylation: A review of animal and human literature. Molecular Genetics and Metabolism. 2014;113(4):243-252.
  7. Morris M, Schneider J, Tangney C. Thoughts on B-vitamins and dementia. Journal of Alzheimer’s Disease. 2006;9(4):429-433.
  8. Durga J, van Boxtel M, Schouten E, Kok F, Jolles J, Katan M et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. The Lancet. 2007;369(9557):208-216.
  9. Smith A, Smith S, de Jager C, Whitbread P, Johnston C, Agacinski G et al. Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial. PLoS ONE. 2010;5(9):e12244.
  10. Seshadri S, Beiser A, Selhub J, Jacques P, Rosenberg I, D’Agostino R et al. Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer’s Disease. New England Journal of Medicine. 2002;346(7):476-483.
  11. den Heijer T, Vermeer S, Clarke R, Oudkerk M, Koudstaal P, Hofman A et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain. 2003;126(1):170-175.
  12. Selley M. A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer’s disease. Neurobiology of Aging. 2007;28(12):1834-1839.
  13. Huang T, Zheng J, Chen Y, Yang B, Wahlqvist M, Li D. High consumption of Ω-3 polyunsaturated fatty acids decrease plasma homocysteine: A meta-analysis of randomized, placebo-controlled trials. Nutrition. 2011;27(9):863-867.
  14. da Silva R, Kelly K, Al Rajabi A, Jacobs R. Novel insights on interactions between folate and lipid metabolism. BioFactors. 2013;40(3):277-283.
  15. Jager C, Oulhaj A, Jacoby R, Refsum H, Smith A. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. International Journal of Geriatric Psychiatry. 2011;27(6):592-600.